Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 502

1.

Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.

Tagaya M, Yoshikawa D, Sugishita Y, Yamauchi F, Ito T, Kamada T, Yoshinaga M, Mukaide D, Fujiwara W, Yokoi H, Hayashi M, Watanabe E, Ishii J, Ozaki Y, Izawa H.

Heart Vessels. 2015 May 29. [Epub ahead of print]

PMID:
26022376
2.

Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis.

Chai-Adisaksopha C, Hillis C, Monreal M, Witt DM, Crowther M.

Thromb Haemost. 2015 May 28;114(4). [Epub ahead of print]

PMID:
26018236
3.

Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda.

Chen CH, Chen MC, Gibbs H, Kwon SU, Lo S, On YK, Rosman A, Suwanwela NC, Tan RS, Tirador LS, Zirlik A.

Int J Cardiol. 2015 Mar 27;191:244-253. doi: 10.1016/j.ijcard.2015.03.369. [Epub ahead of print] Review.

PMID:
25978611
4.
5.

Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin.

Kim E, Ozonoff A, Hylek EM, Berlowitz DR, Ash AS, Miller DR, Zhao S, Reisman JI, Jasuja GK, Rose AJ.

Thromb Haemost. 2015 May 7;114(1). [Epub ahead of print]

PMID:
25948532
6.

The effect of dabigatran on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples.

Bonar R, Favaloro EJ, Mohammed S, Pasalic L, Sioufi J, Marsden K.

Pathology. 2015 Jun;47(4):355-64. doi: 10.1097/PAT.0000000000000252.

PMID:
25938348
7.

Contraindications to Anticoagulation Therapy and Eligibility for Novel Anticoagulants in Older Patients With Atrial Fibrillation.

Steinberg BA, Greiner MA, Hammill BG, Curtis LH, Benjamin EJ, Heckbert SR, Piccini JP.

Cardiovasc Ther. 2015 Apr 30. doi: 10.1111/1755-5922.12129. [Epub ahead of print]

PMID:
25930214
8.

Safety of the direct-acting anticoagulants in patients with atrial fibrillation: a meta-analysis.

Rong F, Jia B, Huang P, Lynn HS, Zhang W.

Thromb Res. 2015 Jun;135(6):1117-23. doi: 10.1016/j.thromres.2015.04.004. Epub 2015 Apr 11.

PMID:
25891842
9.
10.

Dabigatran for the prevention and treatment of thromboembolic disorders.

Enriquez A, Baranchuk A, Redfearn D, Simpson C, Abdollah H, Michael K.

Expert Rev Cardiovasc Ther. 2015 May;13(5):529-40. doi: 10.1586/14779072.2015.1034692. Epub 2015 Apr 5.

PMID:
25843430
11.

[Why NAO: Know How. Why and how to choose the new oral anticoagulant in cardiological clinical practice].

Rossini R, Pecora D, Ferlini M, Gentile F, Moschini L, Pedrinazzi C, Ravizza P, Romano M, Canova P, Oliva F.

G Ital Cardiol (Rome). 2015 Mar;16(3):161-74. doi: 10.1714/1820.19826. Italian.

PMID:
25837460
12.

Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs.

Verheugt FW, Granger CB.

Lancet. 2015 Mar 11. pii: S0140-6736(15)60245-8. doi: 10.1016/S0140-6736(15)60245-8. [Epub ahead of print] Review.

PMID:
25777666
13.

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.

Ruff CT, Giugliano RP, Braunwald E, Morrow DA, Murphy SA, Kuder JF, Deenadayalu N, Jarolim P, Betcher J, Shi M, Brown K, Patel I, Mercuri M, Antman EM.

Lancet. 2015 Mar 10. pii: S0140-6736(14)61943-7. doi: 10.1016/S0140-6736(14)61943-7. [Epub ahead of print]

PMID:
25769361
14.

Cardiological aspects of stroke prevention.

Fisher M, McAllister M.

Circ J. 2015;79(2):271-7. doi: 10.1253/circj.CJ-14-1342. Epub 2015 Jan 7.

15.

Intracranial Hemorrhage Caused by Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) - Multicenter Retrospective Cohort Study in Japan.

Saji N, Kimura K, Aoki J, Uemura J, Sakamoto Y.

Circ J. 2015 Apr 24;79(5):1018-23. doi: 10.1253/circj.CJ-14-1209. Epub 2015 Feb 20.

16.

Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials.

Loffredo L, Perri L, Violi F.

Dig Liver Dis. 2015 May;47(5):429-31. doi: 10.1016/j.dld.2015.01.159. Epub 2015 Feb 7.

PMID:
25732432
17.

Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?

Hanley CM, Kowey PR.

J Thorac Dis. 2015 Feb;7(2):165-71. doi: 10.3978/j.issn.2072-1439.2015.01.23. Review.

18.

Efficacy and safety of oral anticoagulants versus aspirin for patients with atrial fibrillation: a meta-analysis.

Zhang JT, Chen KP, Zhang S.

Medicine (Baltimore). 2015 Jan;94(4):e409. doi: 10.1097/MD.0000000000000409. Review.

PMID:
25634169
19.

Intratumoral hemorrhage in a patient with malignant meningioma under anticoagulant therapy.

Ito Y, Nakajima M, Watari M, Sakamoto T, Hashimoto Y, Tajiri S, Takada A, Ando Y.

J Stroke Cerebrovasc Dis. 2015 Apr;24(4):e91-2. doi: 10.1016/j.jstrokecerebrovasdis.2014.11.008. Epub 2015 Jan 22.

PMID:
25620713
20.

Gastrointestinal bleeding. Gastrointestinal bleeding risk is increased by novel anticoagulants.

Rockey DC.

Nat Rev Gastroenterol Hepatol. 2015 Mar;12(3):131-2. doi: 10.1038/nrgastro.2015.7. Epub 2015 Jan 20.

PMID:
25601661
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk